INTRODUCTION: Tissue engineering of human nasal septal chondrocytes offers the potential to create large quantities of autologous material for use in reconstructive surgery of the head and neck. Culture with recombinant human growth factors may improve the biochemical and biomechanical properties of engineered tissue. The objectives of this study were to (1) perform a high-throughput screen to assess multiple combinations of growth factors and (2) perform more detailed testing of candidates identified in part I. METHODS: In part I, human nasal septal chondrocytes from three donors were expanded in monolayer with pooled human serum (HS). Cells were then embedded in alginate beads for 2 weeks of culture in medium supplemented with 2% or 10% HS and 1 of 90 different growth factor combinations. Combinations of insulin-like growth factor-I (IGF-1), bone morphogenetic protein (BMP)-2, BMP-7, BMP-13, growth differentiation factor-5 (GDF-5), transforming growth factor β (TGFβ)-2, insulin, and dexamethasone were evaluated. Glycosaminoglycan (GAG) accumulation was measured. A combination of IGF-1 and GDF-5 was selected for further testing based on the results of part I. Chondrocytes from four donors underwent expansion followed by three-dimensional alginate culture for 2 weeks in medium supplemented with 2% or 10% HS with or without IGF-1 and GDF-5. Chondrocytes and their associated matrix were then recovered and cultured for 4 weeks in 12 mm transwells in medium supplemented with 2% or 10% HS with or without IGF-1 and GDF-5 (the same medium used for alginate culture). Biochemical and biomechanical properties of the neocartilage were measured. RESULTS: In part I, GAG accumulation was highest for growth factor combinations including both IGF-1 and GDF-5. In part II, the addition of IGF-1 and GDF-5 to 2% HS resulted in a 12-fold increase in construct thickness compared with 2% HS alone (p < 0.0001). GAG and type II collagen accumulation was significantly higher with IGF-1 and GDF-5. Confined compression modulus was greatest with 2% HS, IGF-1, and GDF-5. CONCLUSION: Supplementation of medium with IGF-1 and GDF-5 during creation of neocartilage constructs results in increased accumulation of GAG and type II collagen and improved biomechanical properties compared with constructs created without the growth factors.
INTRODUCTION: Tissue engineering of human nasal septal chondrocytes offers the potential to create large quantities of autologous material for use in reconstructive surgery of the head and neck. Culture with recombinant human growth factors may improve the biochemical and biomechanical properties of engineered tissue. The objectives of this study were to (1) perform a high-throughput screen to assess multiple combinations of growth factors and (2) perform more detailed testing of candidates identified in part I. METHODS: In part I, human nasal septal chondrocytes from three donors were expanded in monolayer with pooled human serum (HS). Cells were then embedded in alginate beads for 2 weeks of culture in medium supplemented with 2% or 10% HS and 1 of 90 different growth factor combinations. Combinations of insulin-like growth factor-I (IGF-1), bone morphogenetic protein (BMP)-2, BMP-7, BMP-13, growth differentiation factor-5 (GDF-5), transforming growth factor β (TGFβ)-2, insulin, and dexamethasone were evaluated. Glycosaminoglycan (GAG) accumulation was measured. A combination of IGF-1 and GDF-5 was selected for further testing based on the results of part I. Chondrocytes from four donors underwent expansion followed by three-dimensional alginate culture for 2 weeks in medium supplemented with 2% or 10% HS with or without IGF-1 and GDF-5. Chondrocytes and their associated matrix were then recovered and cultured for 4 weeks in 12 mm transwells in medium supplemented with 2% or 10% HS with or without IGF-1 and GDF-5 (the same medium used for alginate culture). Biochemical and biomechanical properties of the neocartilage were measured. RESULTS: In part I, GAG accumulation was highest for growth factor combinations including both IGF-1 and GDF-5. In part II, the addition of IGF-1 and GDF-5 to 2% HS resulted in a 12-fold increase in construct thickness compared with 2% HS alone (p < 0.0001). GAG and type II collagen accumulation was significantly higher with IGF-1 and GDF-5. Confined compression modulus was greatest with 2% HS, IGF-1, and GDF-5. CONCLUSION: Supplementation of medium with IGF-1 and GDF-5 during creation of neocartilage constructs results in increased accumulation of GAG and type II collagen and improved biomechanical properties compared with constructs created without the growth factors.
Authors: Thomas H Alexander; August B Sage; Barbara L Schumacher; Robert L Sah; Deborah Watson Journal: Otolaryngol Head Neck Surg Date: 2006-09 Impact factor: 3.497
Authors: Jeremy D Richmon; August B Sage; Elliot Shelton; Barbara L Schumacher; Robert L Sah; Deborah Watson Journal: Laryngoscope Date: 2005-09 Impact factor: 3.325
Authors: David L Hicks; August B Sage; Barbara L Schumacher; Robert L Sah; Deborah Watson Journal: Otolaryngol Head Neck Surg Date: 2005-09 Impact factor: 3.497
Authors: Tommi Tallheden; Josefine van der Lee; Camilla Brantsing; Jan-Eric Månsson; Eva Sjögren-Jansson; Anders Lindahl Journal: Cell Transplant Date: 2005 Impact factor: 4.064
Authors: Angela A Chang; Marsha S Reuther; Kristen K Briggs; Barbara L Schumacher; Gregory M Williams; Maripat Corr; Robert L Sah; Deborah Watson Journal: Otolaryngol Head Neck Surg Date: 2011-10-26 Impact factor: 3.497
Authors: Marsha S Reuther; Kristen K Briggs; Monica K Neuman; Koichi Masuda; Robert L Sah; Deborah Watson Journal: Otolaryngol Head Neck Surg Date: 2013-02-20 Impact factor: 3.497
Authors: Marsha S Reuther; Kristen K Briggs; Barbara L Schumacher; Koichi Masuda; Robert L Sah; Deborah Watson Journal: Laryngoscope Date: 2012-06-27 Impact factor: 3.325
Authors: Deborah Watson; Marsha S Reuther; Van W Wong; Robert L Sah; Koichi Masuda; Kristen K Briggs Journal: Laryngoscope Date: 2016-06-13 Impact factor: 3.325
Authors: Paul W Riem Vis; Joost P G Sluijter; R Sarita Soekhradj-Soechit; Lex A van Herwerden; Jolanda Kluin; Carlijn V C Bouten Journal: J Cell Mol Med Date: 2012-04 Impact factor: 5.310
Authors: Chih-Wen Twu; Marsha S Reuther; Kristen K Briggs; Robert L Sah; Koichi Masuda; Deborah Watson Journal: Allergy Rhinol (Providence) Date: 2014-01